183 related articles for article (PubMed ID: 25780444)
1. Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis.
Yang J; Li J; Dai W; Wang F; Shen M; Chen K; Cheng P; Zhang Y; Wang C; Zhu R; Zhang H; Zheng Y; Wang J; Xia Y; Lu J; Zhou Y; Guo C
Exp Ther Med; 2015 Apr; 9(4):1413-1420. PubMed ID: 25780444
[TBL] [Abstract][Full Text] [Related]
2. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.
Zhou Y; Yin X; Ying J; Zhang B
BMC Cancer; 2012 Jan; 12():17. PubMed ID: 22244200
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis.
Zhu R; Yang J; Xu L; Dai W; Wang F; Shen M; Zhang Y; Zhang H; Chen K; Cheng P; Wang C; Zheng Y; Li J; Lu J; Zhou Y; Wu D; Guo C
Gastroenterol Res Pract; 2014; 2014():529314. PubMed ID: 25165471
[TBL] [Abstract][Full Text] [Related]
4. Whether the Golgi protein 73 could be a diagnostic serological marker in hepatocellular carcinoma: a meta analysis.
Zhang X; Wu LN; Li XQ; Luo X; Liu SW; Zhang L; Nawaz S; Ma LN; Ding XC
BMC Gastroenterol; 2023 Mar; 23(1):85. PubMed ID: 36964524
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
Zhao S; Long M; Zhang X; Lei S; Dou W; Hu J; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):536. PubMed ID: 32411759
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta-analysis.
Zhang Y; Tang J; Zhou X; Zhu SL; Li LQ
Mol Genet Genomic Med; 2020 Feb; 8(2):e1071. PubMed ID: 31777190
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis.
Zhang J; Shao C; Zhou Q; Zhu Y; Zhu J; Tu C
Mol Clin Oncol; 2015 Sep; 3(5):1165-1171. PubMed ID: 26623071
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of serum Golgi protein-73 (GP73) combined with AFP-L3% in hepatocellular carcinoma: a meta-analysis].
Shi M; Huang Z; Yang Y; Zhao B
Zhonghua Gan Zang Bing Za Zhi; 2015 Mar; 23(3):189-93. PubMed ID: 25938831
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of Golgi protein 73 in primary hepatic carcinoma using ELISA: a systematic review and meta-analysis.
Cao FF; Yu S; Jiang ZY; Bao YX
Clin Lab; 2014; 60(4):587-97. PubMed ID: 24779292
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis.
Sun T; Tang Y; Sun D; Bu Q; Li P
Onco Targets Ther; 2018; 11():8925-8935. PubMed ID: 30573979
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
Jia X; Liu J; Gao Y; Huang Y; Du Z
Arch Med Res; 2014 Oct; 45(7):580-8. PubMed ID: 25446613
[TBL] [Abstract][Full Text] [Related]
13. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.
Cao Z; Li Z; Wang Y; Liu Y; Mo R; Ren P; Chen L; Lu J; Li H; Zhuang Y; Liu Y; Wang X; Zhao G; Tang W; Xiang X; Wang H; Cai W; Liu L; Zhu C; Bao S; Xie Q
J Viral Hepat; 2017 Nov; 24 Suppl 1():57-65. PubMed ID: 29082644
[TBL] [Abstract][Full Text] [Related]
14. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis.
Zhang J; Zhao Y; Yang Q
Int J Biol Markers; 2014 Dec; 29(4):e403-10. PubMed ID: 24980448
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis.
Liu CH; Gil-Gómez A; Ampuero J; Romero-Gómez M
Liver Int; 2018 Oct; 38(10):1820-1831. PubMed ID: 29704434
[TBL] [Abstract][Full Text] [Related]
17. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.
Liu T; Yao M; Liu S; Wang L; Wang L; Hou J; Ma X; Jia J; Zhao J; Zhuang H; Lu F
Oncotarget; 2017 Mar; 8(10):16498-16506. PubMed ID: 28157705
[TBL] [Abstract][Full Text] [Related]
18. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
[TBL] [Abstract][Full Text] [Related]
19. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
[TBL] [Abstract][Full Text] [Related]
20. [Meta-analysis on the diagnostic value of laser Doppler imaging for burn depth].
Huang Y; Qiu L; Mei AL; Li JX
Zhonghua Shao Shang Za Zhi; 2017 May; 33(5):301-308. PubMed ID: 28651422
[No Abstract] [Full Text] [Related]
[Next] [New Search]
